Release Date: 30/04/10 17:13 Summary: March Quarter Activities Report Price Sensitive: Yes Download Document 900.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%